Financials
Financial year 2025
DRS. REMANS REUMATOLOGIE from Genk, company number BE0822082423, closed financial year 2025 with a result of € 287,911 after tax. For that financial year DRS. REMANS REUMATOLOGIE recorded a gross margin of € 463,548 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 252,178 to € 287,911. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 1.5 million
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 287,911
▲ 14% vs 2024
Profit after tax over the fiscal year.
€ 351,077
▼ 40% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 49,091 paid out
17 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 27,016
▲ 15% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 53,467
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 455
▼ 94% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 67,456
▼ 51% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 349,044 | € 374,584 | € 409,960 | € 463,548 | ▲ 13% |
| Profit after taxes | € 138,644 | € 231,357 | € 252,178 | € 287,911 | ▲ 14% |
| Equity | € 1,013,651 | € 960,008 | € 1,212,187 | € 1,451,007 | ▲ 20% |
| Total debts | € 58,830 | € 346,746 | € 146,479 | € 117,002 | ▼ 20% |
| Cash | € 353,612 | € 511,543 | € 581,558 | € 351,077 | ▼ 40% |
| Retained profit | € 1,007,451 | € 953,808 | € 1,205,987 | € 1,444,807 | ▲ 20% |
| Dividend | € 0 | € 285,000 | € 0 | € 49,091 | |
| Balance sheet total | € 1,072,481 | € 1,306,755 | € 1,358,665 | € 1,568,009 | ▲ 15% |
| Employees (FTE) | 1.5 | 0.6 | 0.5 | - |
By gross margin, DRS. REMANS REUMATOLOGIE ranks 25th of 92 companies with main activity “Activiteiten van medisch specialisten” in Genk that publish figures (fiscal year 2025).
Key figures of DRS. REMANS REUMATOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about DRS. REMANS REUMATOLOGIE the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DRS. REMANS REUMATOLOGIE?
What happened at DRS. REMANS REUMATOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 287,911 (▲ 14% vs 2024). filed late Source: NBB ↗
- New establishment in Genk. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 138,644 profit in 2022 to € 287,911 profit in 2025.
Paid € 420,016 in corporate taxes since 2022.
Best year ever: 2025, with € 287,911 profit.
On average € 232,700 of value added per employee in 2022.
Management
Behind DRS. REMANS REUMATOLOGIE is Philip Remans. It owns 79% of Medisch Centrum Genk itself.
Directors
According to the 2025 annual accounts
Philip Remans
Director
Also active at: SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE, MEDISCH CENTRUM GENK
Establishments
Establishment units
Physical locations of this company
Weg naar As 123
3600 Genk
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Genk
Same main activity (Activiteiten van medisch specialisten), 107 active companies in Genk, largest first.
Medische Beeldvorming Ziekenhuis Oost-Limburg
€ 21 million revenue · 2025
BELGO-INTERNATIONAL RESEARCH APPLICATIONS en DEVELOPMENT
€ 2.4 million gross margin · 2025
€ 1.2 million gross margin · 2025
€ 897,337 gross margin · 2025
€ 859,250 gross margin · 2025
€ 818,343 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- REMANS Philip Herman Jozef(oprichter) 99.5%
- REMANS Joannes Josephus Elisabeth(oprichter) 0.5%
Details
- Company number
- 0822.082.423
- VAT number
- BE 0822.082.423
- Registered office
- Weg naar As 123, 3600 Genk
- Names & denominations
- DRS. REMANS REUMATOLOGIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 January 2010
- Peppol
- Active · Active since 15 Oct 2024
- Activities · NACE
Activiteiten van medisch specialisten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten